Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

Black women with CCCA are more likely to have uterine fibroids.

The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.

Mutations in the hairless gene cause hair loss and skin cysts in rhesus macaques.

Hair shaft changes may be linked to CCCA, but their role is unclear.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Tertiary lymphoid structures are important in immunotherapy and need more research.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

A benign skin tumor was removed from a man's leg, and it didn't come back after 9 months.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Mutations in the hairless gene cause a rare form of permanent hair loss.

Recognizing minor skin lesions can help identify serious cancer syndromes.

CCCA may be caused by both hair traction and an immune response.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

A family was found with both Trichorhinophalangeal syndrome and Loose Anagen Syndrome, suggesting a genetic connection.

Tongue cancer cells show more plectin-1 than non-cancer cells, but both have similar levels of trichohyalin.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

Blocking mTORC1 reduces skin tumor growth in mice.

Recognizing perinevoid alopecia and concentric regrowth is important for diagnosing and treating alopecia areata.

Targeting the TNFRSF1B gene may help treat hair loss.

A unique gene mutation was found in a family with monilethrix.